Non-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast Cancer

(MedPage Today) — CHICAGO — The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women receiving endocrine therapy for hormone receptor (HR)-positive breast cancer or its prevention, the phase…